Nicox SA (ALCOX) EUR1

Sell:€0.31Buy:€0.31€0.01 (1.62%)

Prices delayed by at least 15 minutes
Sell:€0.31
Buy:€0.31
Change:€0.01 (1.62%)
Prices delayed by at least 15 minutes
Sell:€0.31
Buy:€0.31
Change:€0.01 (1.62%)
Prices delayed by at least 15 minutes

Company Information

About this company

Nicox SA is a France-based international ophthalmic company. It is engaged in the field of the research, development and future commercialization of investigational drugs for ophthalmological diseases. The Company’s aim is to build a portfolio of therapeutic products addressing the needs of eye care practitioners and patients. Nicox SA offers its customers the Xailin range of ocular lubricants and AdenoPlus, a diagnostic test that aids in the differential diagnosis of acute conjunctivitis. The Company has also products in the pipeline, such as VESNEO (a drug-candidate for treating glaucoma) and AC-170 (for allergic conjunctivis). It has a direct commercial presence in Germany, France, the United Kingdom, Italy and Spain, as well as partnerships with local distributors in a number of key international markets.

Key people

Gavin Spencer
Chief Executive Officer, Director
Damian Marron
Independent Chairman of the Board
Christine Placet
Director
Michele Garufi
Independent Director
Marc Le Bozec
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    France
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    FR0013018124
  • Market cap
    €21.35m
  • Employees
    5
  • Shares in issue
    50.17m
  • Exchange
    Euronext Paris
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.